399 related articles for article (PubMed ID: 28733791)
1. Current clinical evidence of tocilizumab for the treatment of ANCA-associated vasculitis: a prospective case series for microscopic polyangiitis in a combination with corticosteroids and literature review.
Sakai R; Kondo T; Kurasawa T; Nishi E; Okuyama A; Chino K; Shibata A; Okada Y; Takei H; Nagasawa H; Amano K
Clin Rheumatol; 2017 Oct; 36(10):2383-2392. PubMed ID: 28733791
[TBL] [Abstract][Full Text] [Related]
2. Tocilizumab for polymyalgia rheumatica: report of two cases and review of the literature.
Macchioni P; Boiardi L; Catanoso M; Pulsatelli L; Pipitone N; Meliconi R; Salvarani C
Semin Arthritis Rheum; 2013 Aug; 43(1):113-8. PubMed ID: 23433960
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-6 in ANCA-associated vasculitis: Rationale for successful treatment with tocilizumab.
Berti A; Cavalli G; Campochiaro C; Guglielmi B; Baldissera E; Cappio S; Sabbadini MG; Doglioni C; Dagna L
Semin Arthritis Rheum; 2015 Aug; 45(1):48-54. PubMed ID: 25841802
[TBL] [Abstract][Full Text] [Related]
4. Corticosteroid-free treatment of tocilizumab monotherapy for microscopic polyangiitis: a single-arm, single-center, clinical trial.
Sakai R; Kondo T; Kikuchi J; Shibata A; Chino K; Okuyama A; Takei H; Amano K
Mod Rheumatol; 2016 Nov; 26(6):900-907. PubMed ID: 26934300
[TBL] [Abstract][Full Text] [Related]
5. Tocilizumab for the treatment of large-vessel vasculitis (giant cell arteritis, Takayasu arteritis) and polymyalgia rheumatica.
Unizony S; Arias-Urdaneta L; Miloslavsky E; Arvikar S; Khosroshahi A; Keroack B; Stone JR; Stone JH
Arthritis Care Res (Hoboken); 2012 Nov; 64(11):1720-9. PubMed ID: 22674883
[TBL] [Abstract][Full Text] [Related]
6. Tocilizumab in giant cell arteritis: Multicenter open-label study of 22 patients.
Loricera J; Blanco R; Hernández JL; Castañeda S; Mera A; Pérez-Pampín E; Peiró E; Humbría A; Calvo-Alén J; Aurrecoechea E; Narváez J; Sánchez-Andrade A; Vela P; Díez E; Mata C; Lluch P; Moll C; Hernández Í; Calvo-Río V; Ortiz-Sanjuán F; González-Vela C; Pina T; González-Gay MÁ
Semin Arthritis Rheum; 2015 Jun; 44(6):717-23. PubMed ID: 25697557
[TBL] [Abstract][Full Text] [Related]
7. Tocilizumab monotherapy for polymyalgia rheumatica: A prospective, single-center, open-label study.
Chino K; Kondo T; Sakai R; Saito S; Okada Y; Shibata A; Kurasawa T; Okuyama A; Takei H; Amano K
Int J Rheum Dis; 2019 Dec; 22(12):2151-2157. PubMed ID: 31625288
[TBL] [Abstract][Full Text] [Related]
8. Tocilizumab (Actemra).
Sheppard M; Laskou F; Stapleton PP; Hadavi S; Dasgupta B
Hum Vaccin Immunother; 2017 Sep; 13(9):1972-1988. PubMed ID: 28841363
[TBL] [Abstract][Full Text] [Related]
9. Brief Report: A Prospective Open-Label Phase IIa Trial of Tocilizumab in the Treatment of Polymyalgia Rheumatica.
Lally L; Forbess L; Hatzis C; Spiera R
Arthritis Rheumatol; 2016 Oct; 68(10):2550-4. PubMed ID: 27159185
[TBL] [Abstract][Full Text] [Related]
10. Effects of cyclophosphamide on the prognosis of Japanese patients with renal vasculitis associated with anti-neutrophil cytoplasmic antibody-positive microscopic polyangiitis.
Iwabuchi M; Nakaya I; Tsuchiya Y; Shibagaki Y; Yamaguchi T; Fukuhara S; Oe Y; Sakuma T; Sato T; Taguma Y; Soma J
Clin Exp Nephrol; 2016 Oct; 20(5):712-719. PubMed ID: 26590052
[TBL] [Abstract][Full Text] [Related]
11. Tocilizumab vs placebo for the treatment of giant cell arteritis with polymyalgia rheumatica symptoms, cranial symptoms or both in a randomized trial.
Spiera R; Unizony SH; Bao M; Luder Y; Han J; Pavlov A; Stone JH
Semin Arthritis Rheum; 2021 Apr; 51(2):469-476. PubMed ID: 33784598
[TBL] [Abstract][Full Text] [Related]
12. Tocilizumab monotherapy for large vessel vasculitis: results of 104-week treatment of a prospective, single-centre, open study.
Saito S; Okuyama A; Okada Y; Shibata A; Sakai R; Kurasawa T; Kondo T; Takei H; Amano K
Rheumatology (Oxford); 2020 Jul; 59(7):1617-1621. PubMed ID: 31665468
[TBL] [Abstract][Full Text] [Related]
13. Tocilizumab: a novel therapy for patients with large-vessel vasculitis.
Salvarani C; Magnani L; Catanoso M; Pipitone N; Versari A; Dardani L; Pulsatelli L; Meliconi R; Boiardi L
Rheumatology (Oxford); 2012 Jan; 51(1):151-6. PubMed ID: 22075063
[TBL] [Abstract][Full Text] [Related]
14. Corticosteroids in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.
Keller SF; Miloslavsky EM
Rheum Dis Clin North Am; 2016 Feb; 42(1):91-101, viii. PubMed ID: 26611553
[TBL] [Abstract][Full Text] [Related]
15. Remission Induction Therapy with Rituximab for Microscopic Polyangiitis: A Feasibility Study.
Saito A; Takeuchi Y; Kagaya S; Ojima Y; Fukami H; Sato H; Matsuda K; Nagasawa T
Tohoku J Exp Med; 2017 May; 242(1):53-62. PubMed ID: 28539536
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of large vessel vasculitis in ANCA-associated vasculitis: a retrospective cohort study.
Coattrenec Y; Muller YD; Spoerl D; Lobrinus JA; Seebach JD
Rheumatol Int; 2021 Dec; 41(12):2147-2156. PubMed ID: 34559277
[TBL] [Abstract][Full Text] [Related]
17. Current and emerging treatment options for ANCA-associated vasculitis: potential role of belimumab and other BAFF/APRIL targeting agents.
Lenert A; Lenert P
Drug Des Devel Ther; 2015; 9():333-47. PubMed ID: 25609919
[TBL] [Abstract][Full Text] [Related]
18. Methotrexate versus cyclophosphamide for remission maintenance in ANCA-associated vasculitis: A randomised trial.
Maritati F; Alberici F; Oliva E; Urban ML; Palmisano A; Santarsia F; Andrulli S; Pavone L; Pesci A; Grasselli C; Santi R; Tumiati B; Manenti L; Buzio C; Vaglio A
PLoS One; 2017; 12(10):e0185880. PubMed ID: 29016646
[TBL] [Abstract][Full Text] [Related]
19. Giant cell arteritis successfully treated with subcutaneous tocilizumab monotherapy.
Higashida-Konishi M; Akiyama M; Shimada T; Hama S; Oshige T; Izumi K; Oshima H; Okano Y
Rheumatol Int; 2023 Mar; 43(3):545-549. PubMed ID: 36152056
[TBL] [Abstract][Full Text] [Related]
20. An expanded population of pathogenic regulatory T cells in giant cell arteritis is abrogated by IL-6 blockade therapy.
Miyabe C; Miyabe Y; Strle K; Kim ND; Stone JH; Luster AD; Unizony S
Ann Rheum Dis; 2017 May; 76(5):898-905. PubMed ID: 27927642
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
